VolitionRx Limited announced that Dr. Jason Terrell tendered written notice of his resignation as Chief Medical Officer, effective as of November 18, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.62 USD | -3.88% |
|
+2.48% | -13.53% |
May. 14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.53% | 51.41M | |
+6.28% | 3.52B | |
-10.46% | 2.04B | |
-27.73% | 1.82B | |
-21.74% | 1.65B | |
+6.72% | 928M | |
+29.42% | 811M | |
-8.30% | 702M | |
-27.76% | 522M | |
-12.92% | 255M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- Volitionrx Limited Announces Resignation of Dr. Jason Terrell as Chief Medical Officer